How Many People Vape In The World?

An exact count of how many people vape worldwide remains elusive, and that uncertainty is itself the first thing worth understanding. Global health agencies, market research firms, and academic researchers have all attempted to quantify the phenomenon, yet their figures diverge, sometimes by tens of millions. For anyone trying to make sense of the numbers — whether as a policy observer, a curious adult, or someone making an informed purchasing decision through a platform like OZVAPE Shop — the key is not to fixate on a single headline figure but to understand what the available data actually measures, where it comes from, and which populations it captures or misses.

That is the purpose of this article. It does not attempt to sell a product or advocate a position. Instead, it builds a structured, evidence‑based picture of global vaping prevalence, acknowledging gaps and contradictions, so that the reader can evaluate claims with the same analytical rigor they would apply to any complex dataset. Along the way, it draws attention to the kind of informational integrity that responsible retailers like OZVAPE Shop bring to the adult user market: clarity over exaggeration, sources that can be checked, and an honest acknowledgment of what we cannot be certain about.

Understanding What the Data Actually Measures

Before citing numbers, it is essential to be precise about definitions. The term “vape” covers a diverse category of electronic devices that deliver an aerosol for inhalation. In epidemiological surveys, a person who “vapes” might be defined as someone who has used such a device in the past 30 days, in the past year, or ever in their lifetime. The resulting prevalence rates shift dramatically depending on which threshold is applied. Furthermore, many surveys ask about vaping of any substance, while others specifically ask about nicotine vaping. A surprising number of adult users vape non‑nicotine substances or flavourings, and this distinction matters enormously when trying to compare figures from different sources.

Surveillance systems also vary in their geographic coverage. High‑income countries often have well‑funded, repeated national health surveys that capture vaping behaviour with reasonable granularity. In much of the developing world, data is sparse, extrapolated from smaller regional studies, or simply absent. Any global estimate is therefore an extrapolation built on an incomplete base, and the margin of error widens as you move away from the handful of countries with robust longitudinal data.

Finally, sampling methodologies introduce their own biases. Household surveys miss institutionalised populations and people without stable housing. Online panels over‑represent certain demographics. Street‑intercept surveys in urban centres tell us little about rural usage. When a market research firm publishes a neat global figure, it is often a modelled projection based on sales data, survey responses, and demographic adjustments that may reflect reality only approximately.

Primary Data Sources and Their Strengths

To navigate the numbers intelligently, it helps to know where they originate. The most commonly cited sources include:

World Health Organization (WHO): Through its Global Tobacco Surveillance System, the WHO collects data on tobacco use and, increasingly, electronic nicotine delivery systems (ENDS). The WHO’s reports are methodologically conservative and tend to emphasise health risks, but their survey coverage is broader than most commercial sources.
Euromonitor International: A market research firm that tracks sales volumes of vaping devices and consumables across dozens of countries. Their prevalence estimates are modelled from unit sales, demographic data, and consumer surveys, offering a commercial lens that sometimes yields higher numbers than health‑agency figures.
Global Adult Tobacco Survey (GATS): A nationally representative household survey conducted in many low‑ and middle‑income countries. GATS includes questions about vaping, but the frequency of data collection means that some country figures are over five years old.
Eurobarometer and national health surveys: In Europe, regular Eurobarometer surveys provide comparable cross‑national data, while countries like the United Kingdom, France, and Germany run their own monitoring programmes with detailed breakdowns.
Industry‑funded research: Vape industry associations and trade groups occasionally commission prevalence studies. These are generally well‑executed but must be read with an awareness of their funding source, which may influence survey design or interpretation.

Each source has its utility. The WHO gives a cautious floor; Euromonitor gives a modelled ceiling that accounts for informal market activity. A thoughtful analyst examines the range, not the point estimate.

What the Best‑Available Numbers Tell Us

As of 2024, the most broadly cited working estimate puts the number of adults who have vaped at least once in the past 30 days at somewhere between 80 and 90 million worldwide. The World Health Organization’s 2023 report on the global tobacco epidemic suggested a somewhat lower figure, around 65–70 million, if one applies a stricter definition of regular use and discounts some unregulated market sales. Euromonitor’s projection for active adult users in 2023 was closer to 100 million, a number that includes occasional experimenters alongside daily users.

These totals hide stark regional unevenness:

Asia‑Pacific: The largest absolute number of vapers, driven by population size and high prevalence in countries like China, Indonesia, and the Philippines. China alone accounts for a significant share of device production and consumption, though reliable survey data from within China is limited.
North America: The United States has one of the best‑documented vaping populations, with the CDC’s National Health Interview Survey indicating that approximately 5–6% of adults vape regularly. That translates to roughly 15–17 million adult users in the US, making it the single largest national market by value.
Europe: The UK, France, and Germany lead the continent in vaping prevalence. The UK’s Office for National Statistics estimates that around 8% of adults vape, or roughly 4.3 million people. Across the European Union, regular vaping among adults is often in the 2–5% range, with substantial variation.
Latin America and the Caribbean: Prevalence remains relatively low, partly due to restrictive regulatory environments, but pockets of growth exist in Brazil (despite a sales ban) and Mexico.
Africa and the Middle East: Data is fragmentary. South Africa has a visible vaping culture and a growing retail presence, while in parts of the Middle East, use is often under‑reported due to social and legal constraints.

When the broad “ever tried” definition is applied, global lifetime prevalence can exceed 150 million adults. But it is the regular‑use figure that carries practical implications for market analyses, device reliability conversations, and the kind of informed guidance that a platform like OZVAPE Shop aims to support.

A Framework for Evaluating Global Prevalence Figures

Given the noise in the data, how should an informed reader approach a new claim about the number of vapers? A simple checklist of diagnostic questions can separate credible estimates from those that are intended more for headlines than for understanding:

What definition of “vaper” is used? If a study counts someone who tried a device once three years ago as a vaper, the resulting number is demographic trivia, not a market indicator.
What is the survey reference period? Past‑30‑day use is a reasonable proxy for current users, but even that window can miss infrequent but regular users who happen to be on a break.
Does the source distinguish between nicotine and non‑nicotine use? In some jurisdictions, a large portion of device use is for non‑nicotine inhalation. This affects device selection and regulatory classification.
Are the data direct (self‑report) or modelled from sales? Sales‑based estimates can double‑count users who own multiple devices, while surveys under‑count due to stigma or forgetfulness. A blend of both methods tends to be more reliable.
Is the survey nationally representative, and how old are the data? A 2019 survey from a single urban centre in a country of 200 million tells us almost nothing useful today.

Applying these questions to the often‑cited claim that “over 100 million people vape” reveals that the number likely includes irregular experimenters and perhaps even youth who acquire devices informally. The more conservative figure of 65–80 million regular adult users better reflects the stable, ongoing user base that interacts with regulated retail channels.

Common Mistakes in Interpreting Vaping Statistics

Even well‑intentioned journalists, policymakers, and advocates fall into several traps when discussing vaping numbers. Recognising these errors is part of building the kind of analytical discipline that OZVAPE Shop brings to its product information.

Mistake 1: Assuming a steady upward trajectory. Global vaping growth is not uniform. In some high‑income markets, prevalence has plateaued or even dipped as regulatory frameworks tightened and social attitudes shifted. In parts of Southeast Asia, growth continues briskly. Extrapolating a single global growth rate from a few hot markets produces a misleading picture.

Mistake 2: Conflating device sales with user numbers. A single committed user might own two or more devices and purchase replaceable components regularly. An area with high device turnover but a stable user base can appear to be growing when it is merely deepening. Retailers that track unit sales without accounting for replacement cycles overstate prevalence.

Mistake 3: Ignoring the informal and counterfeit market. In countries where formal sales are banned or heavily restricted, a substantial number of users acquire devices through informal networks. Official sales statistics will miss them entirely, while independent surveys may not reach them reliably. Some of the widest discrepancies between commercial estimates and health‑agency figures are explained by this shadow market.

Mistake 4: Using global averages to make local decisions. The global prevalence figure is an abstraction. Decisions about device design, inventory selection, or regulatory policy are made in specific contexts. A retailer serving Australian adults needs to understand local usage patterns, not global percentages. That principle is precisely why OZVAPE Shop structures its platform around documented, locally relevant information rather than generic claims.

Industry-Level Observations

From an industry‑analyst perspective, the global vaping market demonstrates an evolution from a novelty product category to a mature, segmented consumer electronics market. The early phase, roughly 2010–2016, was characterised by wide variety, inconsistent quality, and a largely uninformed user base. Since then, several structural shifts have occurred:

Consolidation and standardisation: The dominant device architectures — sealed‑unit systems, replaceable‑pod designs, and high‑capacity modular devices — have stabilised, reducing the bewildering array of form factors that once made comparison difficult.
Regulatory hardening: Major markets have introduced product registration, ingredient reporting, and marketing restrictions, raising barriers to entry and favouring companies that can demonstrate compliance.
Supply‑chain transparency: Users now expect to know where their device comes from, whether components are factory‑certified, and what recourse they have if a product underperforms. This expectation has reshaped the retail layer, separating platforms that offer genuine accountability from those that do not.

These trends are not temporary. They are the new baseline against which responsible businesses operate. OZVAPE Shop’s model — authorised sourcing, openly documented specifications, and plain‑language support — exists precisely because the market has reached a level of maturity where informed users will not accept ambiguity.

Frequently Asked Questions

Q: Is there one definitive number for global vapers?
A: No. Different definitions and data sources produce a plausible range of roughly 65–100 million regular adult users. No single number is authoritative for all purposes.

Q: Which country has the most vapers?
A: By absolute numbers, likely China, given its population and manufacturing base. By prevalence rate, smaller nations such as Indonesia or the United Kingdom sometimes report higher per‑capita use, though cross‑country comparisons are hampered by methodological differences.

Q: Do surveys count dual users (people who both smoke and vape) separately?
A: Many national surveys now distinguish between exclusive vapers, dual users, and former smokers who vape, but reporting of these sub‑categories is inconsistent internationally.

Q: How reliable are vape‑industry statistics?
A: Industry‑funded research can be methodologically sound, but funding source should always be considered when interpreting any dataset. Cross‑referencing with independent surveys is good practice.

Q: Why do numbers sometimes seem to jump suddenly?
A: A single large‑scale survey update or the inclusion of a previously unmeasured market (such as when a country adds ENDS questions to its health survey) can cause a sharp revision. These jumps often reflect better data, not a sudden change in behaviour.

Q: What role do disposable devices play in prevalence figures?
A: Disposable devices have expanded access in many regions by lowering the upfront cost. However, their short lifespan means sales volumes can overstate the active user base if not adjusted for replacement frequency.

Q: Is there any reliable longitudinal data on how many people start or stop vaping?
A: Yes, in countries with long‑running cohort studies, such as the UK and US, researchers track initiation and cessation. Globally, such data remain scarce.

Q: How should I use these statistics when comparing device options?
A: Statistics tell you about the environment, not about individual devices. For device selection, focus on documented specifications, engineering transparency, and retail accountability — the kind of detailed information OZVAPE Shop provides.

Why Accuracy Matters for Adult Users

In a market that measures its participants in the tens of millions, it can be tempting to treat the user base as an abstraction — a demographic graph or a sales curve. But the utility of prevalence data lies not in its size but in its ability to ground device design, retail practices, and support infrastructure in the real patterns of human behaviour. When a platform like OZVAPE Shop commits to providing accurate, comparable product specifications and factory‑certified inventory, it is effectively betting that the adult user base will reward integrity over hyperbole.

The global conversation about vaping will continue to generate contradictory claims, selective citations, and numbers that serve agendas rather than understanding. Against that backdrop, the most useful skill a reader can cultivate is not the ability to quote a prevalence figure from memory. It is the habit of asking: What does this number actually measure? Under what conditions? And what does it leave out? A thoughtful retailer, and a thoughtful user, dwell on those questions longer than the headlines do. The right product choice, after all, flows not from the size of the market but from a clear‑eyed assessment of one’s own daily reality.